Phenotypic and genomic comparisons of highly vancomycin-resistant Staphylococcus aureus strains developed from multiple clinical MRSA strains by in vitro mutagenesis
出版年份 2015 全文链接
标题
Phenotypic and genomic comparisons of highly vancomycin-resistant Staphylococcus aureus strains developed from multiple clinical MRSA strains by in vitro mutagenesis
作者
关键词
-
出版物
Scientific Reports
Volume 5, Issue 1, Pages -
出版商
Springer Nature
发表日期
2015-11-25
DOI
10.1038/srep17092
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- “Slow VISA,” a Novel Phenotype of Vancomycin Resistance, FoundIn Vitroin Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Strain Mu3
- (2014) Michie Saito et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Impact of psm-mec in the mobile genetic element on the clinical characteristics and outcome of SCCmec-II methicillin-resistant Staphylococcus aureus bacteraemia in Japan
- (2014) T. Aoyagi et al. CLINICAL MICROBIOLOGY AND INFECTION
- Dissecting Vancomycin-Intermediate Resistance in Staphylococcus aureus Using Genome-Wide Association
- (2014) Md Tauqeer Alam et al. Genome Biology and Evolution
- Generation of a vancomycin-intermediate Staphylococcus aureus (VISA) strain by two amino acid exchanges in VraS
- (2014) A. Berscheid et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Lysocin E is a new antibiotic that targets menaquinone in the bacterial membrane
- (2014) Hiroshi Hamamoto et al. Nature Chemical Biology
- Novel Combinations of Vancomycin plus Ceftaroline or Oxacillin against Methicillin-Resistant Vancomycin-Intermediate Staphylococcus aureus (VISA) and Heterogeneous VISA
- (2013) B. J. Werth et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comprehensive Identification of Mutations Responsible for Heterogeneous Vancomycin-Intermediate Staphylococcus aureus (hVISA)-to-VISA Conversion in Laboratory-Generated VISA Strains Derived from hVISA Clinical Strain Mu3
- (2013) Miki Matsuo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Contribution of Selected Gene Mutations to Resistance in Clinical Isolates of Vancomycin-Intermediate Staphylococcus aureus
- (2012) Cory Hafer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Mutation in the PP2C Phosphatase Gene in a Staphylococcus aureus USA300 Clinical Isolate with Reduced Susceptibility to Vancomycin and Daptomycin
- (2012) Karla D. Passalacqua et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- walKandclpPMutations Confer Reduced Vancomycin Susceptibility inStaphylococcus aureus
- (2011) Mitsutaka Shoji et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mutation of RNA Polymerase β Subunit (rpoB) Promotes hVISA-to-VISA Phenotypic Conversion of Strain Mu3
- (2011) Miki Matsuo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evolution of Multidrug Resistance during Staphylococcus aureus Infection Involves Mutation of the Essential Two Component Regulator WalKR
- (2011) Benjamin P. Howden et al. PLoS Pathogens
- Reduced Vancomycin Susceptibility in Staphylococcus aureus, Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications
- (2010) B. P. Howden et al. CLINICAL MICROBIOLOGY REVIEWS
- Whole-Genome Profiling of Mutagenesis in Caenorhabditis elegans
- (2010) S. Flibotte et al. GENETICS
- Aureusimines in Staphylococcus aureus Are Not Involved in Virulence
- (2010) Fei Sun et al. PLoS One
- Staphylococcus aureus Nonribosomal Peptide Secondary Metabolites Regulate Virulence
- (2010) M. A. Wyatt et al. SCIENCE
- Contribution of vraSR and graSR Point Mutations to Vancomycin Resistance in Vancomycin-Intermediate Staphylococcus aureus
- (2009) L. Cui et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Surface proteins that promote adherence of Staphylococcus aureus to human desquamated nasal epithelial cells
- (2009) Rebecca M Corrigan et al. BMC MICROBIOLOGY
- Genomic Analysis Reveals a Point Mutation in the Two-Component Sensor Gene graS That Leads to Intermediate Vancomycin Resistance in Clinical Staphylococcus aureus
- (2008) B. P. Howden et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Vancomycin-Resistant Staphylococcus aureus in the United States, 2002-2006
- (2008) D. M. Sievert et al. CLINICAL INFECTIOUS DISEASES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started